EFFICACY OF TILDRAKIZUMAB IN MODERATE TO SEVERE PSORIASIS PATIENTS WITH PRIOR EXPOSURE TO APREMILAST

EFFICACY OF TILDRAKIZUMAB IN MODERATE TO SEVERE PSORIASIS PATIENTS WITH PRIOR EXPOSURE TO APREMILAST Meeting Abstract

sustainable development goals

SDG 03: Good Health and Well-being

publication date

January 1, 2018

webpage

Web of Science

published in

ACTA DERMATO-VENEREOLOGICA Journal

start page

29

end page

30

volume

98